[ATX] YoY Quarter Result on 30-Sep-2017 [#Q2]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
29-Sep-2017
Financial Year
2018
Quarter
30-Sep-2017 [#Q2]
Profit Trend
QoQ- 30.58%
YoY- 28.35%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 860 0 51 657 1,182 817 15 96.24%
PBT -1,371 -885 -718 -2,495 -3,482 -2,135 -1,938 -5.60%
Tax -860 -0 0 0 0 0 22 -
NP -511 -885 -718 -2,495 -3,482 -2,135 -1,938 -19.90%
Tax Rate - - - - - - - -
Total Cost 1,371 885 769 3,153 4,665 2,952 1,953 -5.72%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -59.45 0.00 -1,410.33 -379.58 -294.54 -261.48 -13,084.48 -59.26%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.01 -0.02 -0.02 -0.11 -0.17 -0.12 -0.11 -32.92%
EPS Diluted -0.01 -0.02 -0.02 -0.11 -0.17 -0.12 -0.11 -32.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.